Seelos announces second postponement of its annual meeting of stockholders

New york , oct. 24, 2024 /prnewswire/ -- seelos therapeutics, inc. (otcqb: seel) ("seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that its 2024 annual meeting of stockholders (the "annual meeting"), which was previously postponed to friday, october 25, 2024, from its originally scheduled date of friday, september 27, 2024, has been further postponed. the annual meeting is now scheduled to be held virtually, via live webcast at www.virtualshareholdermeeting.com/seel2024, on monday, november 25, 2024 at 8:00 a.m.
SEEL Ratings Summary
SEEL Quant Ranking